New FDA review of AquaBounty shows 'negligible likelihood' its GM farmed salmon would harm environment

The draft assessment was prompted by a 2020 court order to reconsider the company's effect on the US environment and wild salmon.

Sylvia Wulf, CEO of GM salmon producer AquaBounty, said the company is reviewing an FDA draft assessment concerning the company's potential impacts to the environment and to wild salmon in the United States. — Sylvia Wulf, CEO of GM salmon producer AquaBounty, said the company is reviewing an FDA draft assessment concerning the company's potential impacts to the environment and to wild salmon in the United States.Photo: Biotechnology Innovation Organization/YouTube

Rachel Sapin

Published 29 November 2022, 07:01Updated 1 December 2022, 18:42